Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
2.
Pathologica ; 90(6): 801-3, 1998 Dec.
Artigo em Italiano | MEDLINE | ID: mdl-10221003

RESUMO

We report a case of an extramedullary plasmocytoma of the breast in a 71 years old woman who suffered from six years of an osseous plasmocytoma. This lesion is rare and is associated with a serum monoclonal lambda gammopathy. A correct diagnosis of metastasis to the breast is important since the treatment of primary and secondary malignancies of the breast is different.


Assuntos
Neoplasias Ósseas/patologia , Neoplasias da Mama/diagnóstico , Neoplasias da Mama/secundário , Plasmocitoma/patologia , Idoso , Biópsia por Agulha , Neoplasias Ósseas/complicações , Feminino , Humanos , Gamopatia Monoclonal de Significância Indeterminada/complicações , Plasmocitoma/complicações
3.
Perit Dial Int ; 9(4): 273-5, 1989.
Artigo em Inglês | MEDLINE | ID: mdl-2488380

RESUMO

To discover if the management of peritonitis in continuous ambulatory peritoneal dialysis (CAPD) may be effectively simplified by single daily i.p. administration of aztreonam (A) and cefuroxime (C), 10 adult CAPD patients (pts) with peritonitis were trained to start the following treatment procedure: a) sterile collection of dialysate effluent for cultures; b) 4 rapid in-and-out exchanges with antibiotic free dialysate; c) addition of 2 g C and 2 g A to a 2-L exchange for 6-h dwell time (the same dosage was repeated once a day in the overnight exchange); d) routine CAPD exchanges. Concentrations of C and A were measured in dialysate and serum of the patients 2, 12, 18, and 21-23 h after the i.p. administration: C remained within therapeutic range in all samples, while serum and dialysate A levels fell below such range 16 h after the i.p. administration. Seventeen peritonitis episodes occurred during the observation period (12 months): initial dialysate cultures grew Staph. aureus in 6 episodes, Staph epidermidis in 6, Pseudomonas aer. in 2, Streptococcus faecalis in 1, Citrobacter in 1, and Candida in 1. All patients but 1 (with Candida-positive culture) responded to this treatment with no relapse in 2 months. We conclude that once a day i.p. administration of 2 g aztreonam plus 2 g of cefuroxime is an effective and simple way of treating CAPD pts with gram-positive and gram-negative peritonitis.


Assuntos
Aztreonam/administração & dosagem , Cefuroxima/administração & dosagem , Diálise Peritoneal Ambulatorial Contínua/efeitos adversos , Peritonite/tratamento farmacológico , Infecções Estafilocócicas/tratamento farmacológico , Aztreonam/uso terapêutico , Cefuroxima/uso terapêutico , Esquema de Medicação , Quimioterapia Combinada/uso terapêutico , Estudos de Avaliação como Assunto , Humanos , Infusões Parenterais , Falência Renal Crônica/terapia , Pessoa de Meia-Idade , Peritonite/etiologia , Infecções Estafilocócicas/etiologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...